Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05313191 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
A NA study of Breast Cancer and Prostate Cancer, sponsored by The New York Proton Center.
- Recruiting
- Registry status
- NA
- Development phase
- 1,800
- Enrollment target
- 1
- Study location
NCT05313191 is a NA study of Breast Cancer and Prostate Cancer that is actively recruiting participants, run by The New York Proton Center. The registered enrollment target is 1,800 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05313191, a NA study of Breast Cancer and Prostate Cancer, is actively recruiting participants, sponsored by The New York Proton Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,800 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research trial is to study the use of differing investigational doses and scheduling for Proton Therapy for tumors previously treated with radiation therapy. Generally, when patients are first treated for cancer with radiation therapy, they are treated with traditional photon (or x-ray) radiation therapy, which uses high-energy waves to kill tumor cells. In some cases, the cancer either returns or a new tumor can present in a different part of the body. With the usual radiation treatment, the photon beams travel all the way through the body. As a result, healthy tissues in front of and behind the tumor are exposed to radiation. Physicians who treat these cases where the tumor has returned often use a much lower dose of radiation to prevent patients from experiencing serious and long-term side-effects. This dose is often not strong enough to destroy the cancerous tumor. Alternatively, they may also treat a smaller area than would be indicated for complete tumor eradication, again in an attempt to prevent serious and long-term toxicities, but at the cost of optimally treating the cancer. Proton therapy, however, may offer a chance to safely deliver a more effective dose and volume of radiation as it is more targeted and can spare healthy tissues surrounding the tumor. The reason we are conducting this research study is to look at whether Proton therapy can be a better way to treat reoccurring tumors in patients who have previously received radiation therapy to the same area, compared to treatment approaches used to date.
Conditions Studied
Interventions
- RADIATION Pencil Beam Scanning Proton Therapy
Study Locations (1)
New York
- The New York Proton Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2022-01-24 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05313191
The ClinicalTrials.gov registry entry for NCT05313191 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (36% lower). The listed sponsor is The New York Proton Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Pencil Beam Scanning Proton Therapy is the first listed.
NCT05313191 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05313191 about?
NCT05313191 is a clinical study titled "Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors". The goal of this clinical research trial is to study the use of differing investigational doses and scheduling for Proton Therapy for tumors previously treated with radiation therapy. Generally, when patients are first treated for cancer with radiation therapy, they are treated with traditional phot...
What is the current status of trial NCT05313191?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,800 participants. The study started on 2022-01-24. Estimated completion is 2027-01.
What conditions does trial NCT05313191 study?
This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Head and Neck Cancer, Gynecologic Cancer, Thoracic Cancer.
What interventions are being tested in trial NCT05313191?
The interventions under investigation include: Pencil Beam Scanning Proton Therapy (RADIATION).
Who is sponsoring clinical trial NCT05313191?
This trial is sponsored by The New York Proton Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05313191 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.